Agenus Inc., an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, invites investors and the general public to attend its annual meeting of stockholders on June 19, 2019 at 5:00 p.m. ET.
June 13, 2019
· 1 min read